Completed NA INTERVENTIONAL 1-arm NCT05378529

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease

Sponsor: Amgen

Conditions Atherosclerotic Cardiovascular Disease

Interventions Lp(a) Screening

Updated 23 times since 2022 Last updated: Oct 24, 2025 Started: Apr 19, 2022 Primary completion: Dec 30, 2023 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atherosclerotic Cardiovascular Disease and is currently completed. Amgen leads this study, which shows 23 recorded versions since 2022 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

23 versions recorded

Dec 2025 — Present [monthly]

Completed NA
Nov 2025 — Dec 2025 [monthly]

Completed NA
Sep 2025 — Nov 2025 [monthly]

Completed NA
Dec 2024 — Sep 2025 [monthly]

Completed NA
Sep 2024 — Dec 2024 [monthly]

Completed NA

▶ Show 18 earlier versions

Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2024 — Feb 2024 [monthly]

Recruiting NA
Dec 2023 — Jan 2024 [monthly]

Recruiting NA
Nov 2023 — Dec 2023 [monthly]

Recruiting NA
Oct 2023 — Nov 2023 [monthly]

Recruiting NA
Jul 2023 — Oct 2023 [monthly]

Recruiting NA
Jun 2023 — Jul 2023 [monthly]

Recruiting NA
May 2023 — Jun 2023 [monthly]

Recruiting NA
Apr 2023 — May 2023 [monthly]

Recruiting NA
Mar 2023 — Apr 2023 [monthly]

Recruiting NA
Feb 2023 — Mar 2023 [monthly]

Recruiting NA
Dec 2022 — Feb 2023 [monthly]

Recruiting NA
Nov 2022 — Dec 2022 [monthly]

Recruiting NA
Oct 2022 — Nov 2022 [monthly]

Recruiting NA
Sep 2022 — Oct 2022 [monthly]

Recruiting NA
Jul 2022 — Sep 2022 [monthly]

Recruiting NA
Jun 2022 — Jul 2022 [monthly]

Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen

Data source: Amgen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Aachen, Germany , Aalborg, Denmark , Aalst, Belgium , Aarhus N, Denmark , Aberdeen, United Kingdom , Adana, Turkey (Türkiye) , Adelaide, Australia , Afyonkarahisar, Turkey (Türkiye) , Ageo-shi, Japan and 565 more locations